Get notified when SLXN files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SLXN Silexion Therapeutics Corp 8-K

Silexion induces warrant exercise at 75% discount, issues double warrants, raises $1M

Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read

Key Changes

  • high

    Company induced holders of 1,995,092 warrants (originally priced $4.00-$11.32) to exercise at reduced $0.50 price, raising ~$1M gross but issuing 3,990,184 new warrants at same $0.50 price—doubling potential future dilution.

  • high

    New warrants create potential dilution of 3,990,184 shares over 2-5 years if exercised at $0.50, representing significant overhang for existing shareholders at current price levels.

  • medium

    H.C. Wainwright receives 8% cash fees plus 139,656 warrants at $0.625; additional 8% fees apply if new warrants are exercised, creating ongoing dilution and expense.

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.

Partner

Trade SLXN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · May 28, 2026 8:06 PM